Bachem Holding AG (BANB) - Financial and Strategic SWOT Analysis Review

June 2020 | 43 pages | ID: B8761B26B1BEN
GlobalData

Abstracts

Bachem Holding AG (BANB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bachem Holding AG (Bachem) is a technology-based biochemical company that develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers products and services to the pharmaceutical and biotechnology industries. Its products are used for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others. The company research products include catalog products and fluorescent dyes. Its active pharmaceutical ingredients product include NCEs, small molecules APIS and generic APIs. Its services include custom synthesis for peptides and amino acids; new chemical entities services which provides API manufacturing, process development, analytics, project management and regulatory support. The company operates production facilities in the US and Europe. Bachem is headquartered in Bubendorf, Switzerland.

Bachem Holding AG Key Recent Developments

May 25,2020: Bachem ensures global market supply of the active ingredient Propofol from Swiss production site
Mar 13,2020: Bachem Group: Fiscal Year 2019: Record year points to increasing growth dynamics
Mar 03,2020: Changes on the Board Of Directors Of Bachem Holding
Aug 23,2019: Bachem: Half-year report 2019: record sales of 134.5 million CHF and surge in operating income in the first half
Mar 08,2019: Bachem 2018 fiscal year: record sales and increased operating income

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Bachem Holding AG - Key Facts
Bachem Holding AG - Key Employees
Bachem Holding AG - Key Employee Biographies
Bachem Holding AG - Major Products and Services
Bachem Holding AG - History
Bachem Holding AG - Company Statement
Bachem Holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Bachem Holding AG - Business Description
Business Segment: Active Pharmaceutical Ingredients
Overview
Performance
Key Stats
Business Segment: Research Chemicals
Overview
Performance
Key Stats
Geographical Segment: Austria
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Great Britain
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: USA
Performance
Bachem Holding AG - Corporate Strategy
Bachem Holding AG - SWOT Analysis
SWOT Analysis - Overview
Bachem Holding AG - Strengths
Bachem Holding AG - Weaknesses
Bachem Holding AG - Opportunities
Bachem Holding AG - Threats
Bachem Holding AG - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Bachem Holding AG, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 25, 2020: Bachem ensures global market supply of the active ingredient Propofol from Swiss production site
Mar 13, 2020: Bachem Group: Fiscal Year 2019: Record year points to increasing growth dynamics
Mar 03, 2020: Changes on the Board Of Directors Of Bachem Holding
Aug 23, 2019: Bachem: Half-year report 2019: record sales of 134.5 million CHF and surge in operating income in the first half
Mar 08, 2019: Bachem 2018 fiscal year: record sales and increased operating income

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Bachem Holding AG, Key Facts
Bachem Holding AG, Key Employees
Bachem Holding AG, Key Employee Biographies
Bachem Holding AG, Major Products and Services
Bachem Holding AG, History
Bachem Holding AG, Subsidiaries
Bachem Holding AG, Key Competitors
Bachem Holding AG, Ratios based on current share price
Bachem Holding AG, Annual Ratios
Bachem Holding AG, Annual Ratios (Cont...1)
Bachem Holding AG, Annual Ratios (Cont...2)
Bachem Holding AG, Interim Ratios
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Bachem Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Bachem Holding AG, Performance Chart (2015 - 2019)
Bachem Holding AG, Ratio Charts
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Clariant International Ltd
Bio-Gate Ag
Mymetics Corp
Celltrion Inc